Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-12-27 4:12 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | CITADEL ADVISORS LLC | 171,733 0.6% | 171,733 (New Position) | View |
| 2021-10-20 3:42 pm Sale | 13G | GALERA THERAPEUTICS INC GRTX | HIRSCHMAN ORIN | 0 0% | -2,095,291 (Position Closed) | View |
| 2021-06-07 06:18 am Purchase | 13G | GALERA THERAPEUTICS INC GRTX | HIRSCHMAN ORIN | 2,095,291 11% | 358,969 (+20.67%) | View |
| 2021-04-29 6:19 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | HIRSCHMAN ORIN | 1,736,322 11% | 1,736,322 (New Position) | View |
| 2021-02-16 5:01 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Blackstone Holdings I/II GP L.L.C. | 1,687,224 6.8% | 1,687,224 (New Position) | View |
| 2021-02-16 4:08 pm Sale | 13G | GALERA THERAPEUTICS INC GRTX | Venrock Healthcare Capital Partners III L.P. | 917,860 3.7% | -825,528 (-47.35%) | View |
| 2021-02-11 07:45 am Purchase | 13G | GALERA THERAPEUTICS INC GRTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,509,500 6.05% | 209,500 (+16.12%) | View |
| 2021-02-08 4:58 pm Sale | 13G | GALERA THERAPEUTICS INC GRTX | Novo Holdings A/S | 2,959,021 11.9% | -450,000 (-13.20%) | View |
| 2021-02-01 3:50 pm Sale | 13G | GALERA THERAPEUTICS INC GRTX | Novartis Bioventures Ltd | 2,467,960 9.89% | -1,075,107 (-30.34%) | View |
| 2020-11-04 4:52 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Venrock Healthcare Capital Partners III L.P. | 1,743,388 7% | 1,743,388 (New Position) | View |
| 2020-02-14 3:29 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Blackstone Holdings II L.P. | 1,680,632 6.8% | 1,680,632 (New Position) | View |
| 2020-02-13 10:50 am Purchase | 13G | GALERA THERAPEUTICS INC GRTX | New Enterprise Associates 14 L.P. | 4,358,042 17.6% | 4,358,042 (New Position) | View |
| 2020-02-05 12:49 pm Unchanged | 13G | GALERA THERAPEUTICS INC GRTX | Novo Holdings A/S | 3,409,021 13.74% | 0 (Unchanged) | View |
| 2019-11-21 5:28 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Novartis Bioventures Ltd | 3,543,067 14.5% | 3,543,067 (New Position) | View |
| 2019-11-19 8:48 pm Purchase | 13D | GALERA THERAPEUTICS INC GRTX | Sofinnova Venture Partners IX L.P. | 3,084,810 12.7% | 3,084,810 (New Position) | View |
| 2019-11-15 5:08 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,300,000 5.34% | 1,300,000 (New Position) | View |
| 2019-11-14 2:10 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Novo Holdings A/S | 3,409,021 13.99% | 3,409,021 (New Position) | View |